Rongshan Li

6.4k total citations · 1 hit paper
175 papers, 4.1k citations indexed

About

Rongshan Li is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Rongshan Li has authored 175 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 38 papers in Nephrology and 24 papers in Surgery. Recurrent topics in Rongshan Li's work include Renal Diseases and Glomerulopathies (24 papers), Chronic Kidney Disease and Diabetes (12 papers) and Acute Kidney Injury Research (6 papers). Rongshan Li is often cited by papers focused on Renal Diseases and Glomerulopathies (24 papers), Chronic Kidney Disease and Diabetes (12 papers) and Acute Kidney Injury Research (6 papers). Rongshan Li collaborates with scholars based in China, United States and Czechia. Rongshan Li's co-authors include David X. Zhang, David D. Gutterman, Suelhem A. Mendoza, Yafeng Li, Aaron H. Bubolz, Xiaoshuang Zhou, Makoto Suzuki, Hasnaa Yaigoub, Changxin Wu and Hasna Tirichen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rongshan Li

169 papers receiving 4.0k citations

Hit Papers

Mitochondrial Reactive Ox... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongshan Li China 30 1.8k 721 513 488 429 175 4.1k
Tzong‐Shyuan Lee Taiwan 48 3.3k 1.8× 908 1.3× 220 0.4× 434 0.9× 1.2k 2.8× 150 7.4k
Minjie Wei China 30 1.4k 0.7× 717 1.0× 703 1.4× 393 0.8× 358 0.8× 83 5.5k
Assaad A. Eid Lebanon 34 1.4k 0.8× 638 0.9× 438 0.9× 203 0.4× 431 1.0× 131 3.7k
Francisco J. Rios United Kingdom 33 1.2k 0.7× 684 0.9× 110 0.2× 268 0.5× 471 1.1× 86 4.0k
Kenichi Watanabe Japan 45 2.1k 1.1× 680 0.9× 236 0.5× 294 0.6× 523 1.2× 202 6.0k
Shijun Wang China 38 2.4k 1.3× 657 0.9× 257 0.5× 469 1.0× 469 1.1× 206 5.4k
Takeshi Ishii Japan 38 1.5k 0.8× 353 0.5× 191 0.4× 800 1.6× 378 0.9× 159 4.3k
Ganesan Ramesh United States 37 2.1k 1.1× 171 0.2× 1.4k 2.8× 494 1.0× 502 1.2× 66 6.4k
Rolf M. Nüsing Germany 40 1.5k 0.8× 1.1k 1.5× 169 0.3× 579 1.2× 445 1.0× 116 5.1k

Countries citing papers authored by Rongshan Li

Since Specialization
Citations

This map shows the geographic impact of Rongshan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongshan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongshan Li more than expected).

Fields of papers citing papers by Rongshan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongshan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongshan Li. The network helps show where Rongshan Li may publish in the future.

Co-authorship network of co-authors of Rongshan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rongshan Li. A scholar is included among the top collaborators of Rongshan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongshan Li. Rongshan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Rongshan, Xiaoli Shan, Pei Zhao, et al.. (2025). Stachydrine hydrochloride reduces NOX2 activity to suppress oxidative stress levels to improve cardiac insufficiency. Phytomedicine. 140. 156621–156621. 2 indexed citations
3.
Zhang, Zhirong, et al.. (2024). Association of the podocyte phenotype with extracapillary hypercellularity in patients with diabetic kidney disease. Journal of Nephrology. 37(8). 2209–2222. 1 indexed citations
4.
Li, Rongshan, et al.. (2023). Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro. BMJ Open Diabetes Research & Care. 11(2). e003027–e003027. 3 indexed citations
5.
Liao, Hui, et al.. (2023). Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Combined with Multiple Machine Learning Identified a Novel Immune Signature in Diabetic Nephropathy. Diabetes Metabolic Syndrome and Obesity. Volume 16. 1669–1684. 9 indexed citations
6.
Wang, Shuyue, Ruihua Wang, Rongshan Li, & Yafeng Li. (2023). Research Progress on Application of Inonotus obliquus in Diabetic Kidney Disease. Journal of Inflammation Research. Volume 16. 6349–6359. 4 indexed citations
7.
Xu, Shixin, Junjie Liu, Ping He, et al.. (2022). Analysis of clinical predictors of kidney diseases in type 2 diabetes patients based on machine learning. International Urology and Nephrology. 55(3). 687–696. 7 indexed citations
8.
Liao, Hui, et al.. (2022). In Vitro Immunomodulatory Effects of Inonotus obliquus Extracts on Resting M0 Macrophages and LPS-Induced M1 Macrophages. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 8 indexed citations
10.
Guo, Zhaoyang, Liting Wu, Yan Wang, et al.. (2020). Design of Dendritic Large-Pore Mesoporous Silica Nanoparticles with Controlled Structure and Formation Mechanism in Dual-Templating Strategy. ACS Applied Materials & Interfaces. 12(16). 18823–18832. 44 indexed citations
11.
Liao, Hui, et al.. (2020). Protective Effects of Thalidomide on High‐Glucose‐Induced Podocyte Injury through In Vitro Modulation of Macrophage M1/M2 Differentiation. Journal of Immunology Research. 2020(1). 8263598–8263598. 9 indexed citations
12.
He, Jing, Yun Zhou, Na Lv, et al.. (2020). Integrated analysis of miRNA and mRNA expression profiles in the brains of BTBR mice. International Journal of Developmental Neuroscience. 80(3). 221–233. 4 indexed citations
13.
Wei, Hongen, Min Wang, Na Lv, et al.. (2020). Increased repetitive self-grooming occurs in Pax2 mutant mice generated using CRISPR/Cas9. Behavioural Brain Research. 393. 112803–112803. 10 indexed citations
14.
Zhou, Xiaoshuang, et al.. (2019). Deficiency of apoptosis‐stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy. Journal of Cellular and Molecular Medicine. 23(4). 2457–2467. 17 indexed citations
15.
Wang, Yanhong, et al.. (2015). Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation. Clinical and Experimental Medicine. 16(2). 183–192. 16 indexed citations
16.
Li, Rongshan, et al.. (2014). One-pot synthesis of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one derivatives. RSC Advances. 4(99). 55827–55831. 8 indexed citations
17.
Wang, Yinsong, Yinsong Wang, Yang Liu, et al.. (2013). pH-sensitive pullulan-based nanoparticles for intracellular drug delivery. Polymer Chemistry. 5(2). 423–432. 40 indexed citations
18.
Li, Rongshan, et al.. (2013). [Effects of leflunomide on high glucose-induced podocyte cytoskeleton and its mechanism].. PubMed. 93(10). 780–4. 1 indexed citations
19.
Li, Rongshan, et al.. (2010). Synthesis of some new N -[4-acetyl-4,5- dihydro-5-(1-aryl-5-methyl-1 H -1,2,3- triazol-4-yl)-5-methyl-1,3,4-thiadiazol- 2-yl]acetamide derivatives. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 49(4). 521–525. 3 indexed citations
20.
Li, Rongshan, Rui‐Xing Yin, Weixiong Lin, & Yang Dezhai. (2005). [Relationship between the polymorphism of microsomal triglyceride transfer protein gene and the level of serum lipids in Guangxi Heiyi Zhuang population].. PubMed. 85(35). 2492–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026